CVS Health Financials - Benzinga

CVS Health Corp

CVSNYSE

Trade with Public

Trade with Public

$84.61

-1.25-1.46%

最終更新: Sep 24, 1:34 PM

概要ニュース業績予想イベント目標株価財務センチメント株主構成配当比較オプション株式レポート

CVS Health Financials

CVS Health (CVS) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Eli Lilly's Weight-Loss Empire Keeps Expanding As Mounjaro, Zepbound Generate Nearly $15 Billion

Eli Lilly (LLY) beat Q2 earnings expectations & raised 2026 guidance as Mounjaro and Zepbound drove $22.97B in revenue. Read more.

Vandana Singh

CVS Targets Affordable GLP-1 Access With New Eli Lilly Deal

CVS Health beats Q2 earnings expectations and hikes FY26 guidance, but shares fall on profit-taking. Get the full financial breakdown.

Vandana Singh

PRO
CORRECTION: CVS Health Raises FY2026 Adj EPS Guidance from $7.30-$7.50 to $7.90-$8.10 vs $7.45 Est; FY2026 Revenue expected to be more than $414.000B vs $409.235B Est

Benzinga Newsdesk

PRO
CVS Health Raises FY2026 GAAP EPS Guidance from $6.24-$6.44 to $6.84-$7.04 vs $6.12 Est

CVS Health (NYSE:CVS) raises FY2026 GAAP EPS guidance from $6.24-$6.44 to $6.84-$7.04 vs $6.12 analyst estimate..

Benzinga Newsdesk

PRO
CVS Health Q2 Adj. EPS $2.58 Beats $1.85 Estimate, Sales $106.096B Beat $100.114B Estimate

Benzinga Newsdesk

These Analysts Increase Their Forecasts On CVS Health After Strong Q1 Results

CVS Health (NYSE:CVS) reported upbeat Q1 earnings & raised 2026 guidance. Analysts have positive outlook with price targets raised.

Avi Kapoor

© 2026 Benzinga | All Rights Reserved